Novel septin family pseudogene (ENSG00000285268)

ENSG00000285268, known as the novel septin family pseudogene, is annotated in human gene databases as a pseudogene[1]. Pseudogenes are segments of DNA that resemble genes but are generally non-functional due to the presence of mutations that prevent their transcription or translation into functional proteins. While septins are a family of GTP-binding proteins involved in diverse cellular processes such as cytokinesis and cytoskeletal organization, this particular pseudogene does not appear to encode a functional protein, and no characterized biological function or disease association has been reported for ENSG00000285268. Accordingly, it is not considered a valid therapeutic target or biologically active receptor, enzyme, transporter, or other classically druggable molecule[1]. This entry is not a therapeutically actionable target; pseudogenes are not typically considered receptors, enzymes, or other direct drug targets unless demonstrated otherwise. There is nothing to suggest this pseudogene has biological or clinical significance at this time. There are no common aliases or alternative names reported for this entity. The entry "novel septin family pseudogene" should not be confused with functional septin proteins such as SEPTIN9 or SEPTIN12, which are involved in cytoskeletal organization and are implicated in certain diseases[2][4]. In contrast, pseudogenes are annotated as such because they lack coding potential or biological function, unless proven otherwise.